Board of Trustees
Members-at-large
Mr. George Bickerstaff (Chairperson)
Partner and Managing Director,
M.M. Dillon & Co.
U.S.A.
Dr. J. Joseph Kim
President & CEO
Inovio Pharmaceuticals
U.S.A.
Prof. Fred N. Binka
Professor
University of Health and Allied Sciences
Ghana.
Dr. George R. Siber (Chair of Scientific Committee)
Chief Scientific Officer
ClearPath Vaccines
U.S.A.
Dr. Hanna Nohynek (Vice Chair)
Chief Physician & Team Leader
Vaccine Programme Development
National Institute for Health and Welfare (THL) Finland
Dr. Chris Varma
Co-founder, President, CEO & Chairman
Vision Medicines, Inc.
Boston, MA, U.S.A.
Mr. Malcolm Sweeney (Chair, Finance Committee)
Director of Finance EMEA
NComputing UK Ltd
UK
Dr. Ralf Clemens
Principal and Founder
Grid Europe Consulting
Germany
Ziad Ahmed A. Memish
Senior consultant Infectious Diseases
Director Research Department
Prince Mohamed Bin Abdulaziz Hospital
Ministry of Health, Saudi Arabia
Anthony Ford-Hutchinson
CSO, Ribonova, Inc
Independent Pharmaceutical Industry
USA
Representatives of WHO, UNDP, and Host Country (Republic of Korea)
Dr. Takeshi Kasai
Regional Director
International Vaccine Institute
WHO Western Pacific Regional Office (WPRO)
Manila, Philippines
Mr. Ki-hwan Kweon
Director General
International Organizations Bureau
Ministry of Foreign Affairs
Republic of Korea
Dr. Youngmee Jee
Director General
Center for Pathology and Immunology
National Institute of Health
Korea Centers for Disease Control & Prevention
Republic of Korea
United Nations Development Programme
Vacant
Representatives of State Parties to Establishment Agreement
Dr. Catharina Maijgren Steffensson
Associate Director, Medical Director Nordics
Sarepta Therapeutics
Sweden
Dr. Balram Bhargava
Secretary, Department of Health Research & Director General
Indian Council of Medical Research
India
Ex-officio
Dr. Jerome Kim
Director General
International Vaccine Institute
